AAAAAA

   
Results: 1-9 |
Results: 9
Semiquantitative detection of JCV-DNA in peripheral blood leukocytes from HIV-1-Infected patients with or without Progressive Multifocal Leukoencephalopathy
Authors: Andreoletti, L Lescieux, A Lambert, V Si-Mohamed, A Matta, M Wattre, P Belec, L
Citation: L. Andreoletti et al., Semiquantitative detection of JCV-DNA in peripheral blood leukocytes from HIV-1-Infected patients with or without Progressive Multifocal Leukoencephalopathy, J MED VIROL, 66(1), 2002, pp. 1-7
Polymerase chain reaction for Y chromosome to detect semen in cervicovaginal fluid: a prerequisite to assess HIV-specific vaginal immunity and HIV genital shedding
Authors: Chomont, N Gresenguet, G Hocini, H Becquart, P Matta, M Andreoletti, L Si-Mohamed, A Carreno, MP Kazatchkine, M Belec, L
Citation: N. Chomont et al., Polymerase chain reaction for Y chromosome to detect semen in cervicovaginal fluid: a prerequisite to assess HIV-specific vaginal immunity and HIV genital shedding, AIDS, 15(6), 2001, pp. 801-802
Quantitation of human immunodeficiency virus type 1 (HIV-1) RNA in cell-free cervicovaginal secretions: Comparison of reverse transcription-PCR amplification (AMPLICOR HIV-1 MONITOR 1.5) with enhanced-sensitivity branched-DNA assay (Quantiplex 3.0)
Authors: Si-Mohamed, A Andreoletti, L Colombet, I Carreno, MP Lopez, G Chatelier, G Kazatchkine, MD Belec, L
Citation: A. Si-mohamed et al., Quantitation of human immunodeficiency virus type 1 (HIV-1) RNA in cell-free cervicovaginal secretions: Comparison of reverse transcription-PCR amplification (AMPLICOR HIV-1 MONITOR 1.5) with enhanced-sensitivity branched-DNA assay (Quantiplex 3.0), J CLIN MICR, 39(6), 2001, pp. 2055-2059
Cervicovaginal secretory antibodies to human immunodeficiency virus type 1(HIV-1) that block viral transcytosis through tight epithelial barriers inhighly exposed HIV-1-seronegative African women
Authors: Belec, L Ghys, PD Hocini, H Nkengasong, JN Tranchot-Diallo, J Diallo, MO Ettiegne-Traore, V Maurice, C Becquart, P Matta, M Si-Mohamed, A Chomont, N Coulibaly, IM Wiktor, SZ Kazatchkine, MD
Citation: L. Belec et al., Cervicovaginal secretory antibodies to human immunodeficiency virus type 1(HIV-1) that block viral transcytosis through tight epithelial barriers inhighly exposed HIV-1-seronegative African women, J INFEC DIS, 184(11), 2001, pp. 1412-1422
In vitro inactivation of Chlamydia trachomatis and of a panel of DNA (HSV-2, CMV, adenovirus, BK virus) and RNA (RSV, enterovirus) viruses by the spermicide benzalkonium chloride
Authors: Belec, L Tevi-Benissan, C Bianchi, A Cotigny, S Beumont-Mauviel, M Si-Mohamed, A Malkin, JE
Citation: L. Belec et al., In vitro inactivation of Chlamydia trachomatis and of a panel of DNA (HSV-2, CMV, adenovirus, BK virus) and RNA (RSV, enterovirus) viruses by the spermicide benzalkonium chloride, J ANTIMICRO, 46(5), 2000, pp. 685-693
Phenotypic resistance to protease inhibitors in patients who fail on highly active antitetroviral therapy predicts the outcome at 48 weeks of a five-drug combination including ritonavir, saquinavir and efavirenz
Authors: Piketty, C Race, E Castiel, P Belec, L Peytavin, G Si-Mohamed, A Gonzalez-Canali, G Weiss, L Clavel, F Kazatchkine, MD
Citation: C. Piketty et al., Phenotypic resistance to protease inhibitors in patients who fail on highly active antitetroviral therapy predicts the outcome at 48 weeks of a five-drug combination including ritonavir, saquinavir and efavirenz, AIDS, 14(5), 2000, pp. 626-628
Selection of drug-resistant variants in the female genital tract of human immunodeficiency virus type 1-infected women receiving antiretroviral therapy
Authors: Si-Mohamed, A Kazatchkine, M Heard, I Goujon, C Prazuck, T Aymard, G Cessot, G Kuo, YH Bernard, MC Diquet, B Malkin, JE Gutmann, L Belec, L
Citation: A. Si-mohamed et al., Selection of drug-resistant variants in the female genital tract of human immunodeficiency virus type 1-infected women receiving antiretroviral therapy, J INFEC DIS, 182(1), 2000, pp. 112-122
High levels of drug-resistant human immunodeficiency virus variants in patients exhibiting increasing CD4+ T cell counts despite virologic failure ofprotease inhibitor-containing antiretroviral combination therapy
Authors: Belec, L Piketty, C Si-Mohamed, A Goujon, C Hallouin, MC Cotigny, S Weiss, L Kazatchkine, MD
Citation: L. Belec et al., High levels of drug-resistant human immunodeficiency virus variants in patients exhibiting increasing CD4+ T cell counts despite virologic failure ofprotease inhibitor-containing antiretroviral combination therapy, J INFEC DIS, 181(5), 2000, pp. 1808-1812
Efficacy of a five-drug combination including ritonavir, saquinavir and efavirenz in patients who failed on a conventional triple-drug regimen: phenotypic resistance to protease inhibitors predicts outcome of therapy
Authors: Piketty, C Race, E Castiel, P Belec, L Peytavin, G Si-Mohamed, A Gonzalez-Canali, G Weiss, L Clavel, F Kazatchkine, MD
Citation: C. Piketty et al., Efficacy of a five-drug combination including ritonavir, saquinavir and efavirenz in patients who failed on a conventional triple-drug regimen: phenotypic resistance to protease inhibitors predicts outcome of therapy, AIDS, 13(11), 1999, pp. F71-F77
Risultati: 1-9 |